Gout clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 18 years and up
This trial will compare two effective therapies, allopurinol and febuxostat, to lower serum uric acid and therefore prevent further gout attacks. These therapies have never been compared at appropriate doses. Further, they will be studied in patients with kidney disease for the first time.
at UCSD UCSF